Advertisement

Topics

PAION AG: Remimazolam Phase III Colonoscopy Data to Be Presented at the American College of Gastroenterology 2016 Meeting

08:43 EDT 22 Sep 2016 | FinanzNachrichten

Phase III colonoscopy study data accepted as a late breaker Primary investigator Prof. Douglas Rex will present study data on Tuesday, 18 October 2016 PAION AG, a specialty pharma company (ISIN DE...

Original Article: PAION AG: Remimazolam Phase III Colonoscopy Data to Be Presented at the American College of Gastroenterology 2016 Meeting

NEXT ARTICLE

More From BioPortfolio on "PAION AG: Remimazolam Phase III Colonoscopy Data to Be Presented at the American College of Gastroenterology 2016 Meeting"

Quick Search
Advertisement
 

Relevant Topic

Clincial Trials
In a clinical trial or interventional study, participants receive specific interventions according to the research plan or protocol created by the investigators. These interventions may be medical products, such as drugs or devices; procedures; or change...